The transcriptional control of genes involved in inflammation plays a critical role in host defense against pathogens, as well as in the development of inflammatory diseases. At the chromatin level, the gene activity is governed largely by post-translational nuclear protein modifications, including the protein lysine acetylation. The lysine acetylation of histones or non-histone proteins controls transcription by assembly of structurally and functionally distinct transcription complexes. The complex assembly relies on acetyl lysine interaction with the specialized bromodomain (BRD) that are present in numerous nuclear proteins. The BRD-containing proteins (BCP) have recently emerged as promising targets for the development of specific interaction inhibitors, enabling a novel exciting strategy for the development of new therapies, including treatment of inflammation. Recently we discovered a novel mechanism that contributes to suppression of pro-inflammatory genes in macrophages. We identified a regulatory circuit where the bromodomain-containing protein BRD9 supports expression of a subset of non-coding RNAs, including the lncRNA RNU11 that suppresses TNF? and IL6 expression in LPS activated macrophages. In this proposal, we will address the role of BRD9 and BRD9- controlled lncRNA in regulation of the gene expression and inflammatory responses. We also describe an innovative methodology that utilizes the genome-wide CRISPR-mediated mutagenesis in human macrophages for identification of novel regulators of inflammation, including factors that contribute to the function of lncRNA.

Public Health Relevance

We propose to address the mechanism and physiological significance of the novel negative regulators of inflammatory gene expression. We found that members of the structurally-related subfamily of the bromodomain-containing proteins (BCP) suppress inflammatory gene expression in activated macrophages. Recently, we discovered a novel mechanism that contributes to BCP-mediated suppression of pro- inflammatory genes in macrophages. We identified a novel regulatory circuit where the bromodomain- containing protein BRD9 supports expression of a subset of non-coding RNAs, including the lncRNA RNU11 that suppresses TNF? and IL6 expression in LPS activated macrophages. Using in vitro and in vivo genetic approaches, as well as the chromatin and transcriptional analysis, we will identify the mechanism of the lncRNA function and address the significance of lncRNA inflammation in vivo. The proposed program will provide a fundamentally novel insight into transcriptional control of inflammation and will suggest novel approaches for the pharmacological control of inflammation by targeting the specific subsets of bromodomain-containing proteins.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
3R01GM112811-02S1
Application #
9106612
Study Section
Cellular and Molecular Immunology - A Study Section (CMIA)
Program Officer
Dunsmore, Sarah
Project Start
2015-01-15
Project End
2018-12-30
Budget Start
2016-01-01
Budget End
2016-12-31
Support Year
2
Fiscal Year
2016
Total Cost
$228,825
Indirect Cost
$93,825
Name
Rockefeller University
Department
Microbiology/Immun/Virology
Type
Other Domestic Higher Education
DUNS #
071037113
City
New York
State
NY
Country
United States
Zip Code
10065
Tarakhovsky, Alexander; Prinjha, Rab K (2018) Drawing on disorder: How viruses use histone mimicry to their advantage. J Exp Med 215:1777-1787
Dobenecker, Marc-Werner; Park, Joon Seok; Marcello, Jonas et al. (2018) Signaling function of PRC2 is essential for TCR-driven T cell responses. J Exp Med 215:1101-1113
Razooky, Brandon S; Obermayer, Benedikt; O'May, Joshua Biggs et al. (2017) Viral Infection Identifies Micropeptides Differentially Regulated in smORF-Containing lncRNAs. Genes (Basel) 8:
von Schimmelmann, Melanie; Feinberg, Philip A; Sullivan, Josefa M et al. (2016) Polycomb repressive complex 2 (PRC2) silences genes responsible for neurodegeneration. Nat Neurosci 19:1321-30
Tough, David F; Tak, Paul P; Tarakhovsky, Alexander et al. (2016) Epigenetic drug discovery: breaking through the immune barrier. Nat Rev Drug Discov 15:835-853
Yoshida, Hideyuki; Bansal, Kushagra; Schaefer, Uwe et al. (2015) Brd4 bridges the transcriptional regulators, Aire and P-TEFb, to promote elongation of peripheral-tissue antigen transcripts in thymic stromal cells. Proc Natl Acad Sci U S A 112:E4448-57
Sullivan, Josefa M; Badimon, Ana; Schaefer, Uwe et al. (2015) Autism-like syndrome is induced by pharmacological suppression of BET proteins in young mice. J Exp Med 212:1771-81
Dobenecker, Marc-Werner; Kim, Jong Kyong; Marcello, Jonas et al. (2015) Coupling of T cell receptor specificity to natural killer T cell development by bivalent histone H3 methylation. J Exp Med 212:297-306
Schaefer, Anne; Sampath, Srihari C; Intrator, Adam et al. (2009) Control of cognition and adaptive behavior by the GLP/G9a epigenetic suppressor complex. Neuron 64:678-91